The Vanguard Group 13D and 13G filings for Inovio Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 5:06 pm Purchase |
2023-12-29 | 13G | Inovio Pharmaceuticals, Inc. INO |
The Vanguard Group | 19,766,042 7.240% |
18,345,834 (+1291.77%) |
Filing |
| 2023-02-09 11:22 am Purchase |
2022-12-30 | 13G | Inovio Pharmaceuticals, Inc. INO |
The Vanguard Group | 1,420,208 6.830% |
500,266 (+54.38%) |
Filing |
| 2022-02-10 08:17 am Purchase |
2021-12-31 | 13G | Inovio Pharmaceuticals, Inc. INO |
The Vanguard Group | 919,943 5.250% |
154,473 (+20.18%) |
Filing |
| 2021-02-10 11:04 am Purchase |
2020-12-31 | 13G | Inovio Pharmaceuticals, Inc. INO |
The Vanguard Group | 765,470 5.420% |
344,437 (+81.81%) |
Filing |